Baseline blood immunological profiling differentiates between Her2–breast cancer molecular subtypes: implications for immunomediated mechanisms of treatment response
暂无分享,去创建一个
I. Berindan‐Neagoe | O. Bălăcescu | O. Tudoran | C. Gherman | B. Fetica | L. Bălăcescu | C. Lisencu | O. Virtic | L. Balacescu